◆ 会议时间：2026年10月28日-11月1日
◆ 会议地点：韩国 首尔
◆ 会议简介
2026年第28届亚太风湿病协会联盟(APLAR)大会将于2026年10月28日-11月1日在韩国首尔举行，会议由亚太风湿病学会联盟(APLAR)组织。亚太风湿病学大会（APLAR年会）是交流风湿病学领域前沿科学研究和临床信息的重要活动，会议为风湿病学家、内科医生、骨科医生、临床免疫学家、物理学家、物理和职业治疗师、儿科医生和研究人员提供了一个最佳的讨论该地区肌肉骨骼疾病等方面信息的平台。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)
亚太风湿病协会联盟（APLAR）于1963年在悉尼成立，原是澳大利亚、印度、日本和新西兰四个国家成立的SEAPAL（东南亚和太平洋地区抗风湿病联盟），随着不断的发展，后改名为亚太风湿病协会联盟（APLAR）。APLAR隶属于ILAR（国际风湿病协会联合会）。APLAR由亚洲太平洋地区各国的风湿病学学会组成，现包括30个国家风湿病协会成员，APLAR所覆盖的地理区域从大洋洲的新西兰一直延伸到中东的约旦，通过会员协会代表25,000多名风湿病学家，是亚太地区最具影响力的风湿病学专业机构之一。APLAR致力于在亚太地区宣宣传和促进风湿病学科的发展工作。APLAR出版“APLAR风湿病学”杂志，并每年组织亚太地区最具影响力的风湿病学大会。
APLAR 2026 -
28th Asia-Pacific League of Associations for Rheumatology Congress
Date:
October 28 - November 1, 2026
Venue:
COEX Convention & Exhibition Center
Seoul, Republic of Korea
Organized by:
Asia-Pacific League of Associations for Rheumatology (APLAR)
摘要征文投稿：
Abstract Submissions
Submissions open
3 September 2025 to 24 April 2026
Abstract acceptance notification
June 2026
点此提交摘要>>>Submit Abstract>>>
Abstract submission guidelines
Outlined below are the guidelines that must be followed when submitting your work to APLAR 2026.
- All submissions must be in English. English is the official congress language and all presentations must also be in English
- Submission titles must not be longer than 20 words and must clearly indicate the nature of the presentation
- Submissions must not exceed 400 words, be clear and concise, highlight relevant aspects, findings and conclusions
- Only standard abbreviations may be used within submissions
- References are not required for submissions
- The abstract title, section headings and references are not included in the overall word count
- Abstracts should follow the following format
- Background/Purpose: background or statement of purpose
- Methods: methods, materials and analytical procedure used
- Results: summary of the results in sufficient detail to support conclusion (we do not recommend including “results will be discussed”)
- Conclusion: conclusions reached
- Tables, graphs and images are permitted within submissions (maximum 2)
- What is an encore presentation?
An encore presentation is one where you have already presented the submitted work before. For example if you have presented the work at another rheumatology event.
- Does APLAR 2026 accept encore presentations?
- Yes we do accept encore presentations
- Encore presentations are permitted as long as work has been presented after APLAR 2025 (3 – 7 September 2025)
- Encore presentations are permitted as long as work has not previously been published prior to submission
- Encore submissions are required to disclose the name and date of the event where it has been presented
- Original abstracts are strongly recommended
IMPORTANT
- Please enter submission information carefully, information will be published exactly as submitted.
- All abstract submissions must be received online through the abstract submission portal.
Abstract submission topics
- Advances in pain management
- Allied health: alternative medicine
- Allied health: case report
- Allied health: COVID-19
- Allied health: nursing
- Allied health: physiotherapy
- Allied health: psychological intervention and miscellaneous forms of care
- Antiphospholipid syndrome
- Autoinflammatory diseases
- Basic science related to rheumatic diseases
- Behcet’s disease and miscellaneous rheumatic conditions
- Big data
- Case report
- Clinical immunology related to rheumatic diseases
- COVID-19
- Crystal-induced diseases
- Epidemiology, COPCORD, health care system and pharmacoeconomics
- Fibromyalgia
- Genetics
- IgG4-related disease
- Imaging techniques and diagnosis
- Infection-related rheumatic diseases
- Medical technologies and innovation (including AI)
- Metabolic bone diseases
- Osteoarthritis
- Paediatric rheumatology
- Precision medicine
- Psoriatic arthritis
- Rehabilitation for rheumatic diseases
- Rheumatoid arthritis anti-TNF therapy
- Rheumatoid arthritis bDMARDs
- Rheumatoid arthritis clinical aspects and co-morbidity
- Rheumatoid arthritis csDMARDs
- Rheumatoid arthritis non biological treatment
- Rheumatoid arthritis non-TNF biological therapies
- Rheumatoid arthritis tsDMARDs
- Scleroderma, myositis and related syndromes
- Sjogren syndrome
- Soft tissue rheumatism
- Spondylarthropathies biological and non-biological therapies
- Spondylarthropathies clinical aspects and co-morbidity
- Systemic lupus erythematosus, Sjogrens and antiphospholipid syndrome clinical aspects, comorbidities and complications
- Systemic lupus erythematosus, Sjogrens and antiphospholipid syndrome therapies
- Systemic vasculitis related to rheumatic diseases
- Telemedicine
Abstracts can be submitted for either oral or poster presentations.
Oral presentations
Oral presentations will be asked to present an oral presentation at the congress including a PowerPoint presentation and Q&A with the audience.
Poster presentations
Poster presentations will be asked to present a traditional physical poster display.
The APLAR Executive Committee and Korean College of Rheumatology extend their warmest welcome to you for the 28th Asia-Pacific League of Associations for Rheumatology Congress in Seoul.
The congress will be held from 28 October 2026 (Wednesday) to 1 November 2026 (Sunday) at the COEX Convention & Exhibition Center in Seoul, South Korea, Republic of Korea. It will be a celebration of not just the fantastic hospitality and welcoming nature of our Korean colleagues, but also the perfect location to bring together the whole of our cohort of colleagues from across the Asia-Pacific region.
We hope that this congress marks both a unique and personal experience for attendees, in Seoul as our world-class host city, as well as another milestone in APLAR’s efforts to bridge communication and culture barriers for rheumatologists, physicians, nurses, researchers, and allied health professionals working to understand and fight rheumatic diseases across the breadth of the Asia-Pacific region.
The congress will draw on international, regional, and local Korean speakers to provide world-class research, scientific, and medical content for our attendees. The APLAR 2026 Congress theme will be reflected through the scientific program, harnessing amazing recent growth in the number of high-quality abstract submissions for the APLAR congress, and pairing this with the strengths of a local program supported by luminaries from the Korean College of Rheumatology.
We eagerly anticipate your presence in South Korea in October 2026, as we embark on another milestone in our collective journey toward a better understanding and management of rheumatic diseases in our region. We look forward to welcoming you to Seoul in October 2026.
Sincerely,
Dr Jose Paulo Lorenzo
APLAR President
Philippine Rheumatology Association
Prof Shin-Seok Lee
APLAR 2026 Seoul Congress Chair
Korean College Of Rheumatology
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
